Endophenotypes in the personality disorders by Siever, Larry J.
he classification of the personality disorders has
posed a challenge to epidemiologists,clinicians,geneticists,
and psychologists. Because of the varied academic per-
spectives on these disorders that range from behaviorist to
interpersonal to psychodynamic to trait theory, the
schemata that have evolved to categorize the personality
disorders have been highly variable and controversial.The
result has been a nomenclature for these disorders
defined, for example, in the Diagnostic and Statistical
Manual of Mental Disorders, 4th Edition (DSM-IV) in
polythetic criteria that in some cases reflect an epidemio-
logical and/or behavioral tradition,such as antisocial per-
sonality disorder,or in other cases,a psychoanalytically ori-
ented tradition,such as in narcissistic personality disorder.
An alternative approach to understanding and classifying
psychiatric disorders,which has not been extensively inves-
tigated in the personality disorders,is reframing the diag-
nostic nomenclature in terms of specific and measurable
biologically and/or genetically based endophenotypes,
which open up the possibility of identifying genetic pre-
disposing factors, as well as providing a possibly more
rational classification schema.This approach, while not
necessarily incompatible with other diagnostic approaches
that are formulated from alternative perspectives such as
behavioral or psychodynamic approaches,raises the pos-
sibility of generating an underlying “vocabulary”of per-
sonality disorders grounded in specific biologic substrates.
Combinations of these endophenotypically based dimen-
sions of personality disorders,such as affective instability
or impulsivity/aggression,might then become the basis of
more complex multifactorial personality disorders recog-
nized by the clinician,such as borderline personality dis-
order (BPD) or schizotypal personality disorder (SPD).
Furthermore,such an endophenotypic approach may help
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The identification of endophenotypes in the personality
disorders may provide a basis for the identification of
underlying genotypes that influence the traits and
dimensions of the personality disorders, as well as sus-
ceptibility to major psychiatric illnesses. Clinical dimen-
sions of personality disorders that lend themselves to the
study of corresponding endophenotypes include affec-
tive instability, impulsivity, aggression, emotional infor-
mation processing, cognitive disorganization, social
deficits, and psychosis. For example, the propensity to
aggression can be evaluated by psychometric measures,
interview, laboratory paradigms, neurochemical imaging,
and pharmacological studies. These suggest that aggres-
sion is a measurable trait that may be related to reduced
serotonergic activity. Hyperresponsiveness of amygdala
and other limbic structures may be related to affective
instability, while structural and functional brain alter-
ations underlie the cognitive disorganization in psychotic-
like symptoms of schizotypal personality disorder. Thus,
an endophenotypic approach not only provides clues to
underlying candidate genes contributing to these behav-
ioral dimensions, but may also point the way to a better
understanding of pathophysiological mechanisms.  
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with environmental influences.By identifying measurable
characteristics that reflect an underlying genotype or are
more closely related to that genotype than to the diag-
nostic category itself,the opportunity to unravel patho-
physiological pathways involving specific candidate genes
as well as environmental influences on their expression
becomes a more feasible possibility.
There are a variety of endophenotypic strategies,includ-
ing identifying specific clinical characteristics of a disor-
der,for example,age of onset,positive family history,or
suicide history.
1An endophenotypic strategy for person-
ality disorders might also be based on an underlying
dimensional structure of the personality disorders,which
has gained increasing acceptance among investigators in
the field.
2,3Thus,the strategy of identifying intermediate
phenotypes for dimensions of impulsivity, aggression,
affective instability,and emotional information process-
ing in the cluster B disorders;dimensions of psychotic-
like perceptual distortions,social deficits,and cognitive
impairment in the cluster A disorders;and dimensions of
anxiety and behavioral inhibition,and compulsivity in the
cluster C personality disorders may be a promising one
(Table I).While a dimensional approach is defined at the
level of psychopathology,cognitive neuroscience can pro-
vide measurable characteristics of performance in
domains such as sustained attention or working memory.
At a more fundamental psychophysiological or neuro-
physiological level, characteristics such as P50 evoked
potentials, eye movement dysfunction, or startle/blink
paradigms can provide promising endophenotypes that
have proved useful in the schizophrenia spectrum.
3At a
more fundamental biological level,neurochemical para-
meters,including receptor binding or neuroimaging vari-
ables,may be useful as potential endophenotypes.
Ideally,an endophenotype would have high concordance
in twins with a high monozygotic-to-dyzygotic twin ratio,
high correlation in sibpairs, longitudinal stability in
patients and control cohorts, and high discriminability
between patients with a specific diagnostic category in
comparison to healthy or psychiatric comparison groups.
It is desirable for an endophenotype to have a specific
mode of inheritance as well,and it is particularly impor-
tant for it to be relatively convenient and accessible to
measure in order to feasibly evaluate the characteristic
in large populations.
4 Criteria have been developed for
the identification of endophenotypes for use in psychi-
atric genetic studies and include:
•An association with the illness in the general population.
• Heritability and emergence before the onset of illness.
• State independence.
• Close segregation with the illness in families.
• Higher prevalence in nonaffected family members than
in the general population,although less than in affected
family members.
Because the personality disorders, by definition, repre-
sent relatively enduring or persistent traits or coping
styles, which may be in some cases related to the sus-
ceptibility to major Axis I disorders (eg,SPD to schizo-
phrenia, avoidant personality disorder to social phobia
or generalized anxiety disorder), they may lend them-
selves particularly well to endophenotypic approaches.
In this overview,we focus on specific dimensions of per-
sonality disorder that may represent behavioral inter-
mediate phenotypes and discuss more biologically based
endophenotypes that may underlie these dimensions,
with a particular focus on several prototypic personality
disorders:BPD,SPD,and avoidant personality disorder.
We start with a review of studies suggesting heritability
for personality disorders and, for our prototypic disor-
ders in particular, we follow this with a discussion of
strategies for genetic studies of personality disorders,
and then we discuss specific prototypical disorders and
related dimensions.
Heritability of personality disorders
Both twin and family studies,including adoptive studies,
strongly suggest a genetic component for personality and
personality disorder diagnosis.These are strongest when
the personality or personality disorder phenotype is for-
mulated in terms of continuous dimensions.Thus,twin
studies,including monozygotic twins reared together and
apart,support a robust genetic influence on personality
dimensions such as neuroticism and extraversion.
5,6Twin
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Selected abbreviations and acronyms
BPD borderline personality disorder
COMT catecholamine O-methyltransferase
CPT Continuous Performance Task
FDG-PET fluorodeoxyglucose positron emission tomogra-
phy
5-HT 5-hydroxytryptamine (serotonin)
HVA homovanillic acid
PSAP Point Subtraction Aggression Paradigm
SPD schizotypal personality disorderstudies have also suggested a genetic substrate for two of
the prototypic disorders we addressed:SPD
7 and BPD.
8
Both twin
9 and family studies
10-12 suggest that specific
dimensions or traits of the personality disorders,such as
impulsivity or affective instability,may be more heritable
than the disorder itself. For example, the dimension of
impulsive aggression,which has been hypothesized to be
a central dimension of BPD,
13 has been shown to have
substantial heritability in at least two twin populations.
14
Thus,these criteria are supported for personality disor-
ders, such as BPD, by numerous family and adoption
studies.
10
A variety of genetic studies,both twin and adoptive,have
also established a genetic basis for schizophrenia spec-
trum that includes both schizophrenia and SPD.
15 Both
family and adoptive studies provide evidence for a
greater prevalence of schizophrenia-related personality
disorders in relatives of schizophrenic subjects,
16 but
genetic loading for schizophrenia in families of schizo-
typal probands may be less robust because schizophre-
nia is not as common or consistent in schizotypal
probands as in family members of schizophrenic
patients.
3Twin studies suggest that differential heritable
factors may in fact be identified within the schizophrenia
spectrum or SPD: one reflecting more psychotic-like
symptoms and the other reflecting more deficit or neg-
ative symptoms.
17,18
Anxiety is increased in relatives of patients with cluster
C diagnosis,the “anxious cluster”
19 including dependent
personality,and continuity of social anxiety has been doc-
umented in twin and longitudinal studies.
20 Complex per-
sonality disorders like borderline and SPD may emerge
from substrates for more than one dimension.We will
review dimensions related to these and other specific
personality disorders.
Strategy for genetic studies of 
prototypic personality disorders
A variety of complementary approaches to identifying
endophenotypes in the personality disorders may provide
convergent validity for the most promising endopheno-
types.Many of these strategies follow directly from the
criteria proposed by Gottesman and Gould
21 and Leboyer
et al.
1 Heritability could be established most definitively
in large samples of twins in an epidemiologically ascer-
tained sample that could provide enough variance for the
major dimensions of these personality disorders.Subjects
would be evaluated for clinical phenotypic measures by
diagnostic interview,self-report measures,and mental sta-
tus evaluations that reflect specific dimensions of psy-
chopathology.Laboratory measures including neuropsy-
chological,psychophysiological,or laboratory behavioral
tests could then be measured in this population to define
potentially heritable endophenotypes.A complementary
approach is to identify such endophenotypes in the per-
sonality disorder in question,such as BPD or SPD,and
demonstrate a specific increase in these endophenotypes
compared with normal control or psychiatric comparison
groups.State independence or longitudinal stability could
be established in longitudinal studies with repeated mea-
sures of the endophenotypic tests of interest. Finally,
genetic studies of clinically identified samples could be
used to determine whether the endophenotypic measure
cosegregates with the illness or personality disorder in
family members,and is also found in nonaffected family
members at a higher rate than in the general population.
These strategies are already being applied to the study of
BPD and,to a lesser extent,SPD.
Endophenotypes in BPD
BPD has been formulated as an emergent personality
disorder grounded in the interaction of underlying genet-
ically based dimensions including impulsive aggression,
affective instability,and altered emotional information
processing. Identifying endophenotypes for these par-
tially discriminable dimensions may thus represent a
more achievable goal than identifying endophenotypes
for the more complex parent disorder.For each dimen-
sion,diagnostic interview criteria,psychometric variables
from self-report measures,laboratory behavioral tests,
neurochemical variables and neuroimaging paradigms,
postmortem neurochemistry and molecular biology tech-
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Table I. Dimensions of cluster A, B, and C disorders. DSM-IV, Diagnostic
and Statistical Manual of Mental Disorders, 4th Edition.
DSM-IV cluster Dimensions
Cluster A disorders • Social deficits
• Psychotic-like perceptional distortions
• Cognitive impairment
Cluster B disorders • Impulsivity
• Aggression
• Affective instability
• Emotional information processing
Cluster C disorders • Anxiety/behavioral inhibition
• Compulsivityniques,as well as brain structural techniques,also repre-
sent potential endophenotypes that may identify promis-
ing genotypes (Figures 1 and 2).
Impulsivity
Impulsivity is a central characteristic of many of the clus-
ter B personality disorders and, as noted above, most
aggressive acts committed by personality-disordered
patients represent impulsive rather than planned aggres-
sion.Impulsive aggression may also be directed toward
the subject himself or herself as in self-injurious behav-
ior.Other forms of impulsive behavior,such as binge eat-
ing,reckless driving,or gambling,may also be observed
in personality-disordered patients.
Impulsivity is thus defined as a propensity or readiness to
act without reflection or appropriate constraint, often
resulting in behaviors that bring on negative consequences
such as aggression;it is a critical dimension of BPD
12 and,
as discussed above,appears to be heritable,relatively sta-
ble in longitudinal studies,and a potential target for both
pharmacological and psychosocial treatment.While impul-
sivity is often expressed in the domain of aggression in
BPD,the two dimensions may be partially discriminable
and will be treated separately.Psychometric measures that
might be used for assessments of impulsive tendencies
include the Barrett Impulsivity Scale (BIS-11)
22,23 and inter-
views that evaluate life history of actual impulsive behav-
iors, such as the Life History of Impulsive Behavior.
24
These psychometric measures may be complemented by
laboratory assessments that identify critical components
of impulsivity.For example,the Immediate Memory Task
(IMT) reflects “attentional impulsivity,” while go/stop
tasks or go/no go Continuous Performance Tasks (CPTs)
reflect a disinhibition or “motor impulsivity.”The Single
Key Impulsivity Paradigm (SKIP) reflects “nonplanning
impulsivity.”Multifactorial analyses of self-report psycho-
metric data support the characterization on these subtypes
of impulsivity (Flory et al,personal communication).Both
preclinical studies
25 and clinical studies suggest that a more
fine-grained multidimensional approach to impulsivity
may be warranted and that nonplanning impulsivity may
be a key ingredient of BPD.
Aggression
One of the more common impulsive behaviors evidenced
by people with BPD are expressions of anger or reactive
Clinical research
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Figure 1. Identifying promising genotypes from a diagnostic category.
Diagnostic category
Mediating dimension/trait
Self-report measure/clinical interview
Laboratory behavioral task performance
Cognitive task performance
Psychophysiological task performance
Functional, structural, and neurochemical imaging
Postmortem neurochemistry, structure, mRNA expression
Genotype
Figure 2. Identifying promising genotypes in borderline personality dis-
order. PSAP, Point Subtraction Aggression Paradigm; CPT,
Continuous Performance Task; IMT, Immediate Memory Task;
fMRI, functional magnetic resonance imaging; PET, positron
emission tomography; mCPP, meta-chlorophenylpiperazine; 5-
HTT, serotonin transporter; 5-HT2a, 5-hydroxytryptamine (sero-
tonin) 2a receptor; IAP, International Affective Picture slide.
Affective instability
Affect response to provocation
fMRI (response IAPs)
Neurochemical probes/
neuroimaging
(physostigmine, procaine)
Genotype
Impulsive aggression
PSAP, CPT, IMT
Blink-Startle Paradigm
fMRI, PET/PSAP
Neurochemical probes/
neuroimaging
(fenfluramine, mCPP, 
5-HTT, 5-HT2a binding)
Genotype
Borderline personality disorderaggression.Thus,the kind of anger that is observed in BPD
patients is an impulsive type of aggression,but the aggres-
sive components may be analyzed by somewhat different
measures than the impulsive components.For example,
psychometric measures designed to measure aggression
include the Buss-Perry Aggression Questionnaire
(BPAQ),
26 as well as measures of life history of overt
aggressive behaviors (life history of aggression [LHA]).
Both measures have well-established psychometric prop-
erties and heritability has been established in twin studies
using the Buss Durkee Hostility Interview (BDHI),
27 a
precursor of the BPAQ.Preliminary data also suggest that
life history of aggression may be heritable.
Laboratory paradigms that assess aggression behav-
iorally are available, including the Point Subtraction
Aggression Paradigm (PSAP).
28 In the PSAP,an experi-
mental subject is instructed to accumulate “points”that
can be exchanged for money and is told that they are
playing in conjunction with a “confederate subject,”while
in reality responses are generated by computer.
Aggressive responses are often retaliatory to provoca-
tions from the “confederate”and do not net the subject
of the study actual “points,” but may be initiated as an
aggressive response to the perceived aggression of the
confederate.The PSAP has been externally validated in
violent and nonviolent male parolees and responses to
this laboratory test have been correlated with other psy-
chometric measures of aggression.
29The heritability of
this laboratory measure has not been definitively estab-
lished,but is being systematically assessed in studies of
twins (Coccaro et al,personal communication).Another
laboratory test for evaluating the propensity for aggres-
sion in response to provocation is the Taylor Aggression
Paradigm,
30 in which aggressive responses to mild elec-
tric shocks are administered to the subject,ostensibly by
a fictitious opponent.Aggressive behavior is evaluated
as a function of the shock intensities administered by the
subject to this fictitious opponent. This paradigm has
been used extensively in the evaluation of alcohol-
induced aggression
31 and has been applied to studies of
reactive aggression in BPD (Coccaro et al,personal com-
munication).Aggressive responding in the PSAP para-
digm is a stable trait that can distinguish between aggres-
sive and nonaggressive subjects, but, for both of these
measures,the precise prevalence in specific personality
disorders,such as BPD,and the degree of genetic influ-
ence on the PSAP has not been determined.Preliminary
data from our laboratory, however, suggest that more
aggressive responses at lower provocation-free interval
on the PSAP can distinguish impulsive aggressive
patients with BPD from patients with other personality
disorders not characterized by aggression or controls
(New et al,unpublished data).These data suggest that a
polymorphism of catecholamine O-methyltransferase
(COMT) is associated with aggressive responses on the
PSAP (Flory et al,unpublished data).
There are also a variety of neuroendocrine/neurochemi-
cal as well as neuroimaging paradigms that suggest possi-
ble endophenotypic measures in the realm of aggression.
The serotonin (5-hydroxytrypamine,5-HT) system is the
neurotransmitter system most consistently implicated in
the pathogenesis of aggression. Fenfluramine, which
releases serotonin and acts directly on serotonin receptors,
stimulates prolactin release, probably by a 
5-HT2C receptor–mediated mechanism. The prolactin
responsiveness to fenfluramine administration thus pro-
vides an indirect reflection of the capacity of the seroton-
ergic system, which depends on available serotonin for
release,reuptake capacity,and receptor sensitivity.Patients
with BPD demonstrate reduced prolactin responses to
fenfluramine compared with controls,
32 and the degree of
response is highly significantly inversely correlated with
scores on the Buss-Durkee “Assault” and “Irritability”
subscales of the Hostility Inventory.Furthermore,reduced
prolactin responses to fenfluramine are particularly asso-
ciated with criteria of impulsivity,intense anger,and self-
damaging acts,but not to other criteria that reflect affec-
tive instability or identity/relational problems.
32 As
neuroendocrine paradigms cannot assess brain respon-
siveness in critical cortical inhibitory regions,serotonergic
probe studies have shifted to assessment of cortical
responses to these probes as assessed by fluorodeoxyglu-
cose positron emission tomography (FDG-PET).
Aggressive patients with BPD in one cohort
33 and BPD
patients in another cohort
34 demonstrated reduced
responses in prefrontal cortex to the administration of fen-
fluramine compared with placebo.These reductions were
particularly pronounced in regions of orbital and ventral
medial prefrontal cortex, while other more posterior
regions did not necessarily differ between the two groups
or were indeed enhanced in the impulsive patient popula-
tions.Furthermore,in the initial fenfluramine study,the
areas of significant correlation of activation in response to
fenfluramine in orbital frontal cortex with amygdalar
activity suggesting an interactive circuit were more exten-
sive in normal controls than they were in impulsive aggres-
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amygdala were more limited.Another serotonergic probe
that has been used to evaluate cortical activation in rela-
tion to aggression that might serve as an endophenotype
is the metabolite of trazadone,meta-chlorophenylpiper-
azine (mCPP).Baseline activity is reduced in male BPD
patients with physical aggression, and mCPP responses
compared with placebo responses are reduced in anterior
cingular gyrus, particularly on the left, in BPD patients
with any type of aggression.
35 Furthermore,in this study as
well,correlations between amygdala and anterior cingu-
late were disrupted in the aggressive BPD patients com-
pared with controls.
36 Finally,reductions in serotonin trans-
porter (5-HTT) binding appear to be associated with
impulsive aggression in BPD patients.
37
These data are consistent with reduced serotonergic facil-
itation via 5-HT2A receptors of prefrontal cortical
inhibitory regions, particularly anterior cingulate and
orbital frontal cortex,which serve to “brake”the amyg-
dala.Thus,reduced serotonergic activity may result in dis-
inhibited aggression generated in response to negatively
evaluated stimuli.This pathophysiological model could
in part emerge from alterations in serotonergic activity,
primarily reduced integrity of prefrontal inhibitory cen-
ters, or exaggerated responsiveness of amygdala and
related limbic structures. Endophenotypes that reflect
reduced serotonergic activity,altered frontal activation,
or enhanced limbic reactivity thus might serve to char-
acterize specific vulnerabilities of this functional circuitry
in aggressive personality disorder patients.They also may
be used in family studies to characterize relatives or in
conjunction with candidate genes, for example, in the
serotonergic system, in association studies. Thus, for
example, a polymorphism in the serotonin transporter
that determines the amount of transporter expressed has
been associated with neuroticism,
38 and aggression in
some studies,
39,40 but not in others.
41The s allele is associ-
ated with impulsivity and BPD in bulimic patients,
42
aggression and violent suicide attempts in schizophrenic
patients,
43,44 aggression in cocaine abusers,
45 and aggres-
sion and suicide in alcoholics,
46,47 and also with a poten-
tial intermediate phenotype of aggression,the blunted
prolactin response to fenfluramine.
48The polymorphism
for tryptophan hydroxylase was reported to be associated
with aggression in one pilot study,
40 and with self-harm in
another.
49 A more recent study suggested association
between the 5-HTR1B receptor in suicide history
50 and
recent data suggest the possibility of a 5-HT2A receptor
polymorphism being associated with self-injurious behav-
ior (New,personal communication).These studies illus-
trate how a dimensional approach might generate inter-
mediate clinical variables or phenotypes to identify
candidate genes of interest.Studies are underway to eval-
uate more objective laboratory evaluations in relation to
these genetypes,such as the PSAP and potentially more
biologically based “endo”-phenotypes based on neu-
roimaging studies.
The catecholaminergic system has also been implicated in
aggression with reduced concentrations of the norepi-
nephrine metabolite,MHPG (3-methoxy-4-hydroxygly-
col),
51 and enhanced growth hormone responses to cloni-
dine
52 reported to be associated with aggression in
personality-disordered patients.Impulsivity,particularly in
relation to hyperactivity and substance abuse, has been
associated with allelic variation in dopaminergic genes
including the dopamine DRD4 receptor,
53 dopamine trans-
porter,
54 D2 receptor,
55 and D3 receptor.
56 Monoamine oxi-
dase A (MAOA), which produces both dopamine and
serotonin as metabolites,has been associated with impul-
sivity.
57-59 Genetic variation of the α2a-adrenergic receptor
has also been associated with impulsiveness and hostility
in normal subjects.
60These studies did not in general use
laboratory intermediate phenotype measures. A poly-
morphism near the val/met allele of COMT has been asso-
ciated with self-reports of aggression as well as aggressive
responses on the PSAP and impulsive errors on the CPT
(Flory et al,unpublished data).
61
Affect regulation
Psychometric measures of affect regulation that could be
used for intermediate phenotypes are the Affective
Lability Scale (ALS),
62 which measures an individual’s
propensity to shift between affects of anger,depression,
elation, and anxiety.The ALS has sound psychometric
properties and good dimensional and diagnostic speci-
ficity.Another measure,the Affective Intensity Measure
(AIM),
63 measures the intensity of the experience of
affect and it has been found to have some modest heri-
tability as well (Coccaro et al,personal communication).
A variety of laboratory and imaging paradigms may pro-
vide potential phenotypes for the affective instability of
BPD,including startle eye blink paradigms which mea-
sure the magnitude of an eye blink in response to nega-
tive (enhancing) eye blink stimuli and positive (reducing)
eye blink stimuli.This test has good test–retest reliability
Clinical research
144and response may be heritable, as suggested by family
studies of schizophrenic patients. Skin conductance
response has also been used to measure emotional
arousal,and has good stability and test-retest reliability.
Finally, corrugated muscle electromyography (EMG)
activity is associated with the valence of affective stimuli
and may differentiate externalizing from internalizing
personalities.
64These paradigms have not been studied
extensively in BPD.Imaging paradigms evaluating func-
tional brain activity in response to emotionally provoca-
tive stimuli may also provide phenotypes for this dimen-
sion.For example,increased amygdala activity has been
reported following emotionally provocative stimuli,
65 and
increased activation of lateral regions of prefrontal cor-
tex,areas implicated in voluntary or effortful control of
behavior, and increased activation of medial superior
frontal cortex,implicated in self-referential perception,
have been demonstrated in BPD patients compared with
controls.
66 Furthermore,in the latter study,the degree of
activation of amygdala correlated with the degree of neg-
ative affective arousal.These psychophysiological and
neuroimaging paradigms can then be studied in relation
to promising candidate genes to identify underlying
genotypes that may contribute to the excessive emotional
lability and reactivity characteristic of a number of per-
sonality disorders in cluster B,particularly BPD.While a
repeat polymorphism,the DRD4 gene has been associ-
ated with a related dimension,novelty-seeking,
53 there
have been few explicit studies of the genetics of affective
instability and none in personality disorders.
Emotional information processing
While emotional lability and reactivity,discussed in the
previous section, generally refer to alterations in the
threshold of emotional reactivity, the processing and
recognition of emotional information may be a partially
discriminable dimension that enables appropriate social
interaction. Impairment in neuronal circuits involving
orbital frontal ventral medial prefrontal cortex and ante-
rior cingulate may mediate the abnormal emotional
information processing.
Psychometric measures that might be used to identify
intermediate phenotypes of this dimension include the
Emotion Attribution Questionnaire (EAQ) (Coccaro et
al,personal communication) identifying a subject’s abil-
ity to identify the emotion of another person in a vignette
such as anger,sadness,fear,and disgust.These are similar
to the emotions expressed in the Ekman Facial Emotional
Recognition Task (EFERT).Indeed,the EFERT can be
used to directly assess emotional information processing
in the laboratory.
67The Emotional Stroop Task
68 may also
be useful in assessing emotional information processing,as
may be the Bechara Gambling Task (BGT) where subjects
need to discriminate advantageous from disadvantageous
decks of card.
69The EFERT is sensitive to ventral medial
prefrontal cortical dysfunction.The Emotional Stroop Task
test asks subjects to name the color of a word presented
and BPD subjects exhibit a delay in naming the color when
emotionally charged words are presented.The stability of
these measures,their discriminability for specific person-
ality disorders such as BPD,and their underlying genetics
are not yet clear,but are a focus of current studies.
The schizophrenia spectrum 
personality disorders (SPD)
A number of critical dimensions underlie the schizo-
phrenia spectrum or cluster A personality disorders.
Cognitive disorganization, as exemplified in disturbed
thinking patterns, odd speech or language, and even
eccentric appearance,is a hallmark of SPD and may par-
allel the more massive cognitive disorganization
observed in schizophrenia.Deficit-like or negative symp-
toms are prominent in SPD and to a lesser degree in
schizoid personality disorder, and seem to represent
attenuated versions of the more severe deficit symptoms
of schizophrenia.The cognitive/perceptual distortions of
SPD represent psychotic-like or positive symptoms anal-
ogous to the positive symptoms of schizophrenia and,
while not meeting criteria for actual hallucinations and
delusions,may reflect the same underlying dimension.
Paranoia, which is characteristic of SPD and paranoid
personality disorder and may reflect an underlying cog-
nitive disorganization,can represent attempt to reorga-
nize perceptions attributing to external sources the
underlying chaos and fragmentation in thinking
processes the individual with SPD experiences. These
dimensions may be more effectively disentangled in SPD,
where their severity is not as marked as in schizophrenia,
and thus provide potential tools to identify genotypes not
only for the spectrum personality disorders but for schiz-
ophrenia itself.For example,positive and negative symp-
toms are highly correlated with each other and with
severity in schizophrenic patients,but may be more fea-
sibly partially isolated as dimensions in SPD.
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Cognitive disorganization
Cognitive disorganization may be evaluated psychometri-
cally as a part of the Schizotypal Personality Questionnaire
(SPQ).
70A number of cognitive domains are specifically
impaired in SPD, including sustained attention as mea-
sured by the CPT,
71 working memory as measured by audi-
tory and visual working memory tasks,
72 and verbal learn-
ing as measured by verbal learning and memory tasks,
such as the California Verbal Learning Task.
72,73 While
these cognitive domains are more severely impaired in
schizophrenia,they are part of a more generalized deteri-
oration in cognitive function with deficits in general intel-
ligence and motor capacity, which are not necessarily
observed in SPD.Thus,the study of SPD may enable iden-
tification of these underlying endophenotypes for specific
cognitive dysfunctions,which may apply to schizophrenia
as well. A number of psychophysiological endopheno-
types,which are being currently applied to studies of schiz-
ophrenic patients and their relatives,have also been use-
fully applied to SPD and may help to clarify underlying
genetic substrates for this dimension.For example,most
schizophrenic patients and their relatives show deficits in
the P50 evoked potential paradigm,which has also been
associated with an altered polymorphism in the α7-nico-
tinic receptor.
74This promising endophenotype has also
been demonstrated to be impaired in schizotypal relatives
of schizophrenic patients
75 and in schizotypal subjects iden-
tified clinically through advertisements.
76A startle-blink
paradigm,in which a prepulse stimuli results in a inhibi-
tion of the postpulse stimuli, has also been found to be
abnormal not only in schizophrenic subjects and their fam-
ily members,but also in schizotypal subjects.
77 Other psy-
chophysiological endophenotypes include impairment in
backward masking performance,antisaccade generation,
and smooth pursuit eye movement impairments.
78 Imaging
paradigms may be used to identify structural and func-
tional brain correlates of these altered cognitive and psy-
chophysiological functions. For example, reduced pre-
frontal volumes may be associated with cognitive
impairment and deficit symptoms of SPD and anomalous
temporal and other lateral cortical region activation dur-
ing cognitive tasks may be associated with cognitive dis-
organization.
A polymorphism of COMT (Val/Met), which has been
associated with working memory and other cognitive
impairments in schizophrenia,
79 also appears to be mod-
estly associated with cognitive,particularly working mem-
ory impairment,in schizotypal subjects (Minzenberg et al,
unpublished data).
80 Other candidate genes that have been
associated with cognitive impairment,such as dysbindin or
GRM3,have yet to be tested in schizotypal subjects.
81
Deficit symptoms
Deficit symptoms may also be assessed as part of the
schizotypal personality questionnaire.Laboratory tests
assessing social and information processing tasks may
also be of use here,in this case,to identify misperceptions
and distortions in information processing that reflect
deficits in social perception (rather than the abnormal
emotional biasing associated with the cluster B disor-
ders). Tests assessing “theory of mind” have been
employed in this regard in subjects with autism.
Cognitive tasks addressing executive function are most
likely to be associated with deficit symptoms.Reduced
volume of frontal cortex has been associated with
increases in deficit symptoms and executive dysfunction
in schizotypal subjects.
82,83 Structural magnetic resonance
imaging (MRI) studies suggest that frontal lobe is rela-
tively preserved as compared to temporal lobe in schizo-
typal subjects,while reductions in both are prominent in
subjects with schizophrenia.FDG-PET studies suggest
that schizotypal subjects show modest reductions in
frontal activation during verbal learning tasks,although
the deficits are not nearly as pervasive or severe as those
in schizophrenic patients.
3 In many regions,activation is
comparable to that observed in normal volunteers and,
in some,there may actually be compensatory activation
(as can also be observed in schizophrenic subjects), in
regions such as Brodmann Area (BA) 10, which may
function as a super executive area in frontal pole.
84 A
working memory functional MRI (fMRI) study also sug-
gests compensatory activation in BA10 and reduced acti-
vation in area BA46 compared with normal controls.
85
While neuroimaging protocols may not be used routinely
for endophenotypes in large-scale genetic studies,they
may be useful in defining candidate genes such as the
COMT polymorphism in more intensively studied
selected clinical samples.
Psychosis
The dimension of psychosis is a critical part of the symp-
tomatology of the schizophrenic disorders and, while
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other schizophrenia-related personality disorders,psy-
chotic-like symptoms are characteristic of people with
SPD,representing attenuated symptoms on this dimen-
sion.Psychotic-like symptoms can be assessed both by
interviewers as part of the schizotypal personality ques-
tionnaire
86 or in the perceptual aberration or Per/Mag
subscales of the Chapman Scales.
87 This dimension or
phenotype has been linked with indices of dopaminergic
activity,and with higher dopaminergic activity associated
with greater psychotic-like symptoms in the schizo-
phrenic disorders. In SPDs, plasma homovanillic acid
(HVA) was found to be higher in patients with SPD com-
pared with normal controls
83 and the plasma HVA con-
centrations were correlated with degree of psychotic-like
symptomatology.
83 In this study,group differences were
abolished after covarying for psychotic-like symptoms.
An identical configuration of results was found in
another partially overlapping cohort of patients using
cerebrospinal fluid (CSF) HVA.
83 Another potential
index of subcortical dopaminergic responsivity can be
assessed by measuring plasma HVA responses to the gly-
copyruvic stressor,2-deoxyglucose (2-DG).By blocking
glucose absorption into brain cells of frontal lobe,2-DG
induces stress responses including plasma cortisol and
HVA increases following 2-DG administration.Patients
with schizophrenia demonstrate elevated HVA responses
to 2-DG compared to controls;schizotypal patients have
normal responses and,compared with normal controls,
reduced cortisol responses.
Functional and structural imaging studies of striatum point
to the possibility of increased dopaminergic activity.Thus,
patients with SPD show increased striatal volume,partic-
ularly in ventral putamen,which may reflect dendritic pro-
liferation secondary to increased dopaminergic activity.
Increased metabolic activation of ventral putamen in SPD
compared with schizophrenia is also consistent with
reduced dopaminergic inhibitory tone and may also be a
promising imaging endophenotype for candidate gene
studies.Finally,amphetamine,by releasing dopamine,will
displace radiotracers that bind the D2 receptor,which can
be evaluated using IBZM ([
123I]iodobenzamide) as a radi-
oligand in single-photon emission computed tomography
(SPECT) studies or in PET studies using raclopride as a
radioligand.A SPECT study utilizing IBZM as a ligand
indicated that SPD subjects have displacement of IBZM
following amphetamine,which is intermediate between
the markedly increased displacement values found in
acute schizophrenic patients and normal controls.
Raclopride displacement studies using PET scanning fol-
lowing amphetamine also suggest significant increases in
raclopride displacement in schizophrenic patients
88 and
such studies are underway in SPD patients.These studies
suggest that dopaminergic activity in subcortex is normal
to modestly increased, but consistently less than that
observed in acutely schizophrenic patients. Thus, the
dopamine system may be better buffered in schizotypal
patients,and dopaminergic indices may provide promising
endophenotypes for a dimension of psychosis in schizo-
phrenia. Candidate genes related to dopamine activity,
such as polymorphisms or haplotypes in the dopamine 
β-hydroxylase gene
89,90 or the dopamine D4 receptor,
3,91,92
have been found to be associated with psychosis-related
symptomatology,but have not yet been assessed in SPD
or in relation to these endophenotypic neurochemical and
imaging endophenotypes.
Avoidant personality disorder
Avoidant personality disorder is prototypical of the anx-
ious or cluster C personality disorders.The anxious clus-
ter personality disorders are characterized by a suscepti-
bility to marked anxiety as well as behavioral patterns
designed to ward off potential future precipitants of anx-
iety.There have been few studies of the neurobiology and
genetics of these disorders to point towards potentially
promising endophenotypes.There is a high comorbidity
between avoidant personality disorder and social pho-
bia.
93 Heritability of social anxiety has been established
in twin studies and longitudinal studies of traits of inhi-
bition, closely related to anxiety, show the stability of
these traits
94 and a familial relationship to major anxiety
disorders.
95 Limited studies suggest alterations in sero-
tonergic receptors in some studies.For example,patients
with social phobia have an enhanced fenfluramine-
induced rise in cortisol compared with normal controls,
but responses to adrenergic probes have been variable.
96
There are also indications of altered dopaminergic activ-
ity in social phobia.
97 However, none of these studies
were performed in patients with personality disorders
such as avoidant personality disorder,and results have
not been compelling or consistent. High, less variable
heart rate has been consistently documented in individ-
uals with behavioral inhibition
94 and,while this has not
been directly evaluated in avoidant personality disorder,
it might be a promising endophenotype for some of the
anxious cluster personality disorders or at least a dimen-sion of behavioral inhibition,which could be evaluated
in these disorders.There have been few genetic studies
using endophenotypes in anxiety-related personality dis-
orders,although the serotonin transporter has been asso-
ciated with neuroticism and harm avoidance in normal
volunteers and substance abusers.
38,98An allelic form of
the DRD4 receptor has been associated with avoidant
personality disorder symptoms
99 as well as with the clus-
ter C personality disorders.
100
Conclusions
Personality disorders lend themselves particularly well
to endophenotype studies, as they represent relatively
stable traits that can be formulated in terms of underly-
ing and interactive dimensions. These in turn may be
associated with laboratory,behavioral,or neurobiologi-
cal “endophenotypes” that bring our understanding
closer to underlying genotypes. A few studies have
already linked clinical dimensions and, in some cases,
neurobiological measures to candidate genes (eg,COMT
polymorphisms with cognitive impairment, 5-HTR1B
polymorphisms with suicidal behavior).However,such
approaches have only recently been applied to the Axis
I disorders and have been initiated in relation to the per-
sonality disorders,which may represent the most preva-
lent phenotypes for underlying genotypes in susceptibil-
ity to major psychiatric disorders. ❏
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Endofenotipos en los trastornos de 
personalidad
La identificación de endofenotipos en los trastor-
nos de personalidad puede proporcionar las bases
para la identificación de genotipos fundamentales
que influyan sobre rasgos y dimensiones de los tras-
tornos de personalidad, como también sobre la sus-
ceptibilidad a las principales enfermedades psi-
quiátricas. Las dimensiones clínicas de los trastornos
de personalidad que se prestan para el estudio de
los endofenotipos correspondientes incluyen la
inestabilidad afectiva, la impulsividad, la agresivi-
dad, el procesamiento de la información emocio-
nal, la desorganización cognitiva, los déficits socia-
les y la psicosis. Por ejemplo, la tendencia a la
agresividad puede ser evaluada mediante medicio-
nes psicométricas, entrevistas, paradigmas de labo-
ratorio, neuroimágenes funcionales y estudios far-
macológicos. Estas evaluaciones sugieren que la
agresividad  es un rasgo medible que puede rela-
cionarse con una disminución de la actividad sero-
toninérgica. La hiperrespuesta de la amígdala y de
otras estructuras límbicas se puede relacionar con
la inestabilidad afectiva, mientras que alteraciones
cerebrales estructurales y funcionales subyacen a la
desorganización cognitiva de los síntomas de tipo
psicótico del trastorno de personalidad esquizotí-
pico. Por lo tanto, una aproximación endofenotí-
pica no sólo proporciona pistas para los genes can-
didato fundamentales que contribuyen a estas
dimensiones conductuales, sino que también puede
iluminar el camino para una mejor comprensión de
los mecanismos fisiopatológicos. 
Les endophénotypes dans les troubles de la
personnalité
L’identification des endophénotypes dans les
troubles de la personnalité peut fournir des bases
à l’identification des génotypes sous-jacents qui
influent sur les caractéristiques et l’étendue des
troubles de la personnalité comme sur la suscepti-
bilité aux maladies psychiatriques majeures.
L’étendue clinique des troubles de la personnalité
qui donnent matière à l’étude des endophénotypes
correspondants comprend l’instabilité affective,
l’impulsivité, l’agression, la transformation de l’in-
formation émotionnelle, la désorganisation cogni-
tive, les inadaptations sociales et la psychose. Par
exemple, la propension aux agressions peut être
évaluée par des mesures psychométriques, des
entretiens oraux, des modèles de laboratoire, de
l’imagerie neurochimique et des études pharmaco-
logiques. Ces éléments suggèrent que l’agression
est une caractéristique mesurable qui peut être
reliée à une activité sérotoninergique réduite.
L’hyperréactivité de l’amygdale et des autres struc-
tures limbiques peut avoir un lien avec une instabi-
lité affective, alors que les altérations cérébrales
structurales et fonctionnelles laissent supposer une
désorganisation cognitive dans les symptômes psy-
chomimétiques des troubles de la personnalité schi-
zotypiques. Ainsi, une approche endophénotypique
ne fournit pas seulement des indices sur les gènes
candidats sous-jacents qui participent à ces dimen-
sions comportementales mais elle peut également
indiquer la voie vers une meilleure compréhension
des mécanismes physiopathologiques.
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